The most recent developments regarding therapies based on incretin hormones (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)) are likely to fundamentally change our therapy for type 2 diabetes mellitus (T2DM), obesity and conditions associated with diabetes and obesity, i
Cognitive focus is enhanced in Hardcore with ingredients like Huperzine A and Synephrine
Share your weight history, past diets, activity limitations, medications, supplements, lab results, and family history
The KLOW blend adds a fourth peptide, KPV (10 mg), on top of the GLOW composition for anti-inflammatory pathway coverage, totalling 80 mg across four peptides
Our microdosing GLP-1 approach starts with very low, individualized doses that are gradually adjusted based on your bodys feedback and goals not a fixed chart